Announced Mon, 29 Jun · 19:07 IST

Re-opened postal ballot amendments passed with 100% approval

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+4.0%1-day move

₹126.65

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+4.0+6.1+8.2+10.3+12.5+13.6+13.6———

Up moveDown movePending

AI summary

iSERA Lifesciences concluded a re-opened postal ballot for two disclosure amendments to its earlier preferential issue (share swap). BSE had raised queries under SEBI ICDR Regulation 163. Both amendments passed 100% in favor: 13 members voted with 5,53,230 valid votes (6.58% of outstanding shares). Resolution 1 fixed a typo in shares allotted to Mr. Dhairyasheel Yadav (4,50,50 corrected to 4,50,500). Resolution 2 added person-wise post-issue holding disclosure for 196 allottees. Underlying preferential issue was already approved on May 21, 2026.

Likely market impact

Unanimous approval clears BSE disclosure queries; preferential issue can proceed. Procedural filing with limited price impact.